Details of the Drug

General Information of Drug (ID: DMFUOM7)

Drug Name
ALN-TTRsc
Synonyms SAR438714
Indication
Disease Entry ICD 11 Status REF
Cardiomyopathy BC43 Phase 3 [1]
Cross-matching ID
TTD ID
D0E9AF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Transthyretin (TTR) TTC1I86 TTHY_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02319005) ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc.